These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32437091)

  • 1. Tumor-suppressor Fbxw7 targets SIK2 for degradation to interfere with TORC2-AKT signaling in pancreatic cancer.
    Zhang MX; Wang H; Sun GP
    Cell Biol Int; 2020 Sep; 44(9):1900-1910. PubMed ID: 32437091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
    Koo J; Wu X; Mao Z; Khuri FR; Sun SY
    J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
    Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
    J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
    Dai XM; Zhang YH; Lin XH; Huang XX; Zhang Y; Xue CR; Chen WN; Ye JX; Lin XJ; Lin X
    Mol Oncol; 2021 Jan; 15(1):228-245. PubMed ID: 33128264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
    Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
    Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
    Wang J; Wang H; Peters M; Ding N; Ribback S; Utpatel K; Cigliano A; Dombrowski F; Xu M; Chen X; Song X; Che L; Evert M; Cossu A; Gordan J; Zeng Y; Chen X; Calvisi DF
    J Hepatol; 2019 Oct; 71(4):742-752. PubMed ID: 31195063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box and WD repeat domain-containing-7 (Fbxw7) protein targets endoplasmic reticulum-anchored osteogenic and chondrogenic transcriptional factors for degradation.
    Yumimoto K; Matsumoto M; Onoyama I; Imaizumi K; Nakayama KI
    J Biol Chem; 2013 Oct; 288(40):28488-502. PubMed ID: 23955342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MYC is a critical target of FBXW7.
    Sato M; Rodriguez-Barrueco R; Yu J; Do C; Silva JM; Gautier J
    Oncotarget; 2015 Feb; 6(5):3292-305. PubMed ID: 25669969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression.
    Mao JH; Kim IJ; Wu D; Climent J; Kang HC; DelRosario R; Balmain A
    Science; 2008 Sep; 321(5895):1499-502. PubMed ID: 18787170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Ou B; Zhao J; Guan S; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Zheng M; Feng H; Lu A
    Cancer Lett; 2016 Oct; 380(2):457-466. PubMed ID: 27423313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
    Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
    Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells.
    Guo Z; Zhou Y; Evers BM; Wang Q
    Biochem Biophys Res Commun; 2012 Feb; 418(2):426-32. PubMed ID: 22285861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin-dependent degradation.
    Fujii Y; Yada M; Nishiyama M; Kamura T; Takahashi H; Tsunematsu R; Susaki E; Nakagawa T; Matsumoto A; Nakayama KI
    Cancer Sci; 2006 Aug; 97(8):729-36. PubMed ID: 16863506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging roles of F-box proteins in pancreatic tumorigenesis.
    Wang H; Maitra A; Wang H
    Semin Cancer Biol; 2016 Feb; 36():88-94. PubMed ID: 26384530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA‑223‑induced inhibition of the
    Liu Z; Ma T; Duan J; Liu X; Liu L
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRL2
    Motomura S; Yumimoto K; Tomonaga T; Nakayama KI
    Oncogene; 2024 Jun; 43(25):1917-1929. PubMed ID: 38698266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXW7 is involved in Aurora B degradation.
    Teng CL; Hsieh YC; Phan L; Shin J; Gully C; Velazquez-Torres G; Skerl S; Yeung SC; Hsu SL; Lee MH
    Cell Cycle; 2012 Nov; 11(21):4059-68. PubMed ID: 23095493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation.
    Richter KT; Kschonsak YT; Vodicska B; Hoffmann I
    Cell Death Differ; 2020 Feb; 27(2):758-772. PubMed ID: 31285543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.